ArticleCNS neuroscience & therapeutics2016

Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients.

Aina Teniente-Serra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.